RT Journal Article
SR Electronic
T1 Feasibility of estimation of aortic wave intensity using non-invasive pressure recordings in the absence of flow velocity in man
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.01.22.20018457
DO 10.1101/2020.01.22.20018457
A1 Hughes, A.D.
A1 Park, C.
A1 Ramakrishnan, A.
A1 Mayet, J.
A1 Chaturvedi, N.
A1 Parker, K.H.
YR 2020
UL http://medrxiv.org/content/early/2020/05/12/2020.01.22.20018457.abstract
AB Background Wave intensity analysis provides valuable information on ventriculo-arterial function, hemodynamics and energy transfer in the arterial circulation. Widespread use of wave intensity analysis is limited by the need for concurrent measurement of pressure and flow waveforms. We describe a method that can estimate wave intensity patterns using only non-invasive pressure waveforms (pWIA).Methods Radial artery pressure and left ventricular outflow tract (LVOT) flow velocity waveforms were recorded in 12 participants in the Southall and Brent Revisited (SABRE) study. Pressure waveforms were analysed using custom-written software to derive the excess pressure (Pxs) which was scaled to peak LVOT velocity and used to calculate wave intensity. These data were compared with wave intensity calculated using the measured LVOT flow velocity waveform. In a separate study, repeat measures of pWIA were performed on 34 individuals who attended 2 clinic visits at an interval of approximately 1 month to assess reproducibility and reliability of the method.Results Pxs waveforms were similar in shape to aortic flow velocity waveforms and the time of peak Pxs and peak aortic velocity agreed closely. Wave intensity estimated using pWIA showed acceptable agreement with estimates using LVOT velocity tracings and estimates of wave intensity were similar to values reported previously in the literature. The method showed fair to good reproducibility for most parameters.Conclusions The Pxs is a surrogate of LVOT flow velocity which, when appropriately scaled, allows estimation of aortic wave intensity with acceptable reproducibility. This may enable wider application of wave intensity analysis to large studies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe SABRE study was funded at baseline by the UK Medical Research Council (MRC), Diabetes UK, and the British Heart Foundation (BHF). The follow-up study in 2008 and 2011 was funded by the Wellcome Trust (067100, 37055891 & 086676/7/08/Z), the BHF (PG/06/145, PG/08/103/26133, PG/12/29/29497 & CS/13/1/30327) and Diabetes UK (13/0004774). AH receives support from the British Heart Foundation, the Economic and Social Research Council (ESRC), the National Institute on Aging, the National Institute for Health Research University College London Hospitals Biomedical Research Centre, the UK Medical Research Council and works in a unit that receives support from the Medical Research Council. CP is supported by a grant from the BHF. AR is supported by a grant from the BHF.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available from the corresponding author, [ADH], upon reasonable request.